2015
DOI: 10.1016/j.molstruc.2014.09.086
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis, molecular modeling and biological evaluation of novel 2-allyl amino 4-methyl sulfanyl butyric acid as α-amylase and α-glucosidase inhibitor

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
3
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 34 publications
(31 reference statements)
1
3
0
Order By: Relevance
“…Our results are agreed with the previous studies [70,73]. According to various in vivo studies, for diabetes care, alpha-amylase inhibition is supposed to be one of the most operative methods [74,75].…”
Section: Antidiabetic Activitysupporting
confidence: 93%
“…Our results are agreed with the previous studies [70,73]. According to various in vivo studies, for diabetes care, alpha-amylase inhibition is supposed to be one of the most operative methods [74,75].…”
Section: Antidiabetic Activitysupporting
confidence: 93%
“…2,32 According to numerous in vivo studies, the inhibition of a-amylase and a-glucosidase is believed to be one of the most effective approaches for diabetes care. [33][34][35][36]…”
Section: Inhibition Of A-amylase and A-glucosidase By Agnpsmentioning
confidence: 99%
“…Among these three AGIs (acarbose, voglibose and miglitol), acarbose has promising effects on several intestinal enzymes; for example, it mainly inhibits α-amylases, including glucoamylase (90%), sucrose (65%), maltase (60%) and isomaltase (10%) [11]. α-Glucosidase is a membrane-bound enzyme found in intestinal cells that catalyses the production of glucose from a carbohydrate source [12] and α-Glucosidase cleaves α-glycosidic bonds. Glucosidase inhibitors can be used as first-line drugs for the treatment of T2DM, because they can lower the rate of carbohydrate absorption and suppress postprandial hyperglycaemia [13,14,15,16,17].…”
Section: Introductionmentioning
confidence: 99%